ProCE Banner Series

APPlexus Hematology: Clinic-Ready Insights from the Top Abstracts Presented at the 2023 Annual Hematology Meeting

APPlexus Hematology is an initiative designed to address educational needs specific to APPs who care for patients with malignant or nonmalignant hematologic disorders. These webinars will navigate the profound insights from the 2023 ASH Annual Meeting (#ASH23) and will deliver innovative, real-time education to NPs and PAs worldwide. Our mission is to bridge knowledge gaps, untangle controversies, and spotlight pivotal abstracts from #ASH23 in a digestible and engaging format.

  AAPA
  | ANCC
Who Should Attend

This program is intended for NPs, PAs, and other healthcare professionals who care for patients with malignant or nonmalignant hematologic disorders.

All Events

APPlexus Hematology: Clinic-Ready Insights from the Top Abstracts Presented at the 2023 Annual Hematology Meeting

Past Events

February

03

2024

8:00 AM - 1:20 PM Eastern Time (ET)

Virtual

February

10

2024

8:00 AM - 1:20 PM Eastern Time (ET)

Virtual

Faculty

Topics

February 3, 2024

Leukemias

Lymphoma I

Lymphoma II

 

February 10, 2024

Multiple Myeloma

Myeloproliferative neoplasms (MPNs)

Non-Malignant Hematology

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
To improve the knowledge, confidence, and skills of NPs/PAs who care for patients with malignant or nonmalignant hematologic disorders regarding the latest updates in guideline-directed evidence-based medicine, therapeutic management, and strategies to improve health equity, ultimately improving clinical outcomes for their patients. 

Target Audience
This program is intended for NPs, PAs, and other healthcare professionals who care for patients with malignant or nonmalignant hematologic disorders. 

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Integrate recent clinical data to tailor and enhance treatment strategies for patients diagnosed with malignant or nonmalignant hematologic conditions.
  • Assess the implications and potential of emerging agents and therapeutic innovations in managing patients with malignant or nonmalignant hematologic disorders.
  • Evaluate the potential impact of contemporary trial outcomes on shaping future treatment paradigms for patients with malignant or nonmalignant hematologic disorders.

Accreditation

See event registration page for accreditation information.

Acknowledgement

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC

Supported by an educational grant from AbbVie Inc.

For customer support please click here.

Mailing Address:

 

Practicing Clinicians Exchange
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191